Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres (Q44878821)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 December 2013

Language	Label	Description	Also known as
English	Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres	scientific article published on 9 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres (English)

1 reference

Europe PubMed Central

7 December 2017

Clostridium difficile

0 references

Spencer E. Harpe

4

1 reference

Europe PubMed Central

7 December 2017

author name string

Amy L Pakyz

1

1 reference

Europe PubMed Central

7 December 2017

Rachel Jawahar

2

1 reference

Europe PubMed Central

7 December 2017

Qin Wang

3

1 reference

Europe PubMed Central

7 December 2017

language of work or name

0 references

publication date

9 December 2013

1 reference

Europe PubMed Central

7 December 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

7 December 2017

69

1 reference

Europe PubMed Central

7 December 2017

4

1 reference

Europe PubMed Central

7 December 2017

1127-1131

1 reference

Europe PubMed Central

7 December 2017

Epidemiology and control of Clostridium difficile infections in healthcare settings: an update

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Multilevel analysis of infectious diseases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Trends in antibacterial use in US academic health centers: 2002 to 2006.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

A review of uses of health care utilization databases for epidemiologic research on therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Clostridium difficile surveillance: a multicenter comparison of LabID events and use of standard definitions

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Hospital-acquired infections--appropriate statistical treatment is urgently needed!

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Clinical recognition and diagnosis of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Host and Pathogen Factors forClostridium difficileInfection and Colonization

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT489

21 January 2018

Identifiers

10.1093/JAC/DKT489

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44878821&oldid=2055061682"